Td Asset Management Inc Incyte Corp Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

A detailed history of Td Asset Management Inc transactions in Incyte Corp stock. As of the latest transaction made, Td Asset Management Inc holds 95,324 shares of INCY stock, worth $6.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
95,324
Previous 86,243 10.53%
Holding current value
$6.72 Million
Previous $5.23 Million 20.5%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$57.33 - $68.61 $520,613 - $623,047
9,081 Added 10.53%
95,324 $6.3 Million
Q2 2024

Aug 02, 2024
SELL
$51.18 - $63.75 $1.69 Million - $2.1 Million
-32,977 Reduced 27.66%
86,243 $5.23 Million
Q1 2024

May 08, 2024
SELL
$56.55 - $66.59 $1.48 Million - $1.74 Million
-26,201 Reduced 18.02%
119,220 $6.79 Million
Q4 2023

Feb 12, 2024
SELL
$52.16 - $64.19 $525,303 - $646,457
-10,071 Reduced 6.48%
145,421 $9.13 Million
Q3 2023

Oct 27, 2023
BUY
$57.77 - $65.93 $1.01 Million - $1.16 Million
17,565 Added 12.73%
155,492 $8.98 Million
Q2 2023

Aug 09, 2023
BUY
$60.95 - $75.51 $415,618 - $514,902
6,819 Added 5.2%
137,927 $8.59 Million
Q1 2023

May 10, 2023
SELL
$70.23 - $86.01 $552,429 - $676,554
-7,866 Reduced 5.66%
131,108 $9.48 Million
Q4 2022

Feb 06, 2023
SELL
$67.18 - $84.11 $236,742 - $296,403
-3,524 Reduced 2.47%
138,974 $11.2 Million
Q3 2022

Nov 07, 2022
SELL
$66.18 - $82.86 $10.2 Million - $12.7 Million
-153,758 Reduced 51.9%
142,498 $9.49 Million
Q2 2022

Aug 04, 2022
SELL
$66.18 - $83.18 $1.67 Million - $2.1 Million
-25,268 Reduced 7.86%
296,256 $22.5 Million
Q1 2022

May 10, 2022
SELL
$66.02 - $79.71 $10.2 Million - $12.3 Million
-154,334 Reduced 32.43%
321,524 $25.5 Million
Q4 2021

Feb 10, 2022
SELL
$63.34 - $74.11 $8.02 Million - $9.39 Million
-126,661 Reduced 21.02%
475,858 $34.9 Million
Q3 2021

Nov 09, 2021
SELL
$68.67 - $84.02 $5.54 Million - $6.77 Million
-80,610 Reduced 11.8%
602,519 $41.4 Million
Q2 2021

Aug 11, 2021
SELL
$79.87 - $87.53 $29.9 Million - $32.7 Million
-374,000 Reduced 35.38%
683,129 $52.8 Million
Q1 2021

May 14, 2021
BUY
$76.02 - $100.5 $1.2 Million - $1.58 Million
15,746 Added 1.51%
1,057,129 $85.9 Million
Q4 2020

Feb 16, 2021
BUY
$80.74 - $97.7 $12 Million - $14.5 Million
148,738 Added 16.66%
1,041,383 $90.6 Million
Q3 2020

Nov 10, 2020
BUY
$85.07 - $109.69 $10.5 Million - $13.6 Million
123,844 Added 16.11%
892,645 $80.1 Million
Q2 2020

Aug 13, 2020
BUY
$74.18 - $108.93 $28.1 Million - $41.3 Million
379,067 Added 97.26%
768,801 $79.9 Million
Q1 2020

May 15, 2020
BUY
$63.18 - $85.97 $10 Million - $13.6 Million
158,639 Added 68.65%
389,734 $28.5 Million
Q4 2019

Feb 11, 2020
SELL
$73.04 - $95.72 $378,639 - $496,212
-5,184 Reduced 2.19%
231,095 $20.2 Million
Q3 2019

Nov 07, 2019
SELL
$72.82 - $86.52 $364,099 - $432,600
-5,000 Reduced 2.07%
236,279 $17.5 Million
Q2 2019

Aug 01, 2019
BUY
$73.52 - $88.7 $89,326 - $107,770
1,215 Added 0.51%
241,279 $20.5 Million
Q1 2019

May 08, 2019
SELL
$63.56 - $88.17 $920,094 - $1.28 Million
-14,476 Reduced 5.69%
240,064 $20.6 Million
Q4 2018

Feb 01, 2019
SELL
$58.5 - $69.94 $434,772 - $519,794
-7,432 Reduced 2.84%
254,540 $16.2 Million
Q3 2018

Nov 01, 2018
SELL
$61.75 - $74.23 $978,305 - $1.18 Million
-15,843 Reduced 5.7%
261,972 $18.1 Million
Q2 2018

Jul 31, 2018
BUY
$60.85 - $83.98 $1.29 Million - $1.79 Million
21,278 Added 8.29%
277,815 $18.6 Million
Q1 2018

May 11, 2018
BUY
$83.06 - $100.98 $344,117 - $418,360
4,143 Added 1.64%
256,537 $21.4 Million
Q4 2017

Feb 02, 2018
BUY
$93.56 - $116.6 $5.52 Million - $6.88 Million
59,028 Added 30.53%
252,394 $23.9 Million
Q3 2017

Nov 09, 2017
BUY
$109.15 - $138.27 $21.1 Million - $26.7 Million
193,366
193,366 $22.6 Million

Others Institutions Holding INCY

# of Institutions
645
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email